The use of endothelial progenitor cells (EPCs) is a promising new treatment option for cardiovascular diseases. Many of the underlying mechanisms that result in an improvement of endothelial function in vivo remain poorly elucidated to this date, however. We summarize the current positions and potential applications of gene-expression profiling in the field of EPC biology. Based on our own and published gene-expression data, we demonstrate that gene-expression profiling can efficiently be used to characterize different EPC types. Furthermore, we highlight the potential of gene-expression profiling for the analysis of changes that EPCs undergo during culture and examine changes in gene transcription in diseased patients. Transcriptome profiling is a powerful tool for the characterization and functional analysis of EPCs in health and disease. Antioxid. Redox Signal. 15, 1029–1042.
Get full access to this article
View all access options for this article.
References
1.
This reference has been deleted.
2.
AlizadehAA, EisenMB, DavisRE, MaC, LossosIS. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403:503–511. 2000.
AsaharaT, MasudaH, TakahashiT, KalkaC, PastoreC. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 85:221–228. 1999.
5.
AsaharaT, MuroharaT, SullivanA, SilverM, van der ZeeRet al.Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275:964–966. 1997.
6.
AsaharaT, TakahashiT, MasudaH, KalkaC, ChenDet al.VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J, 18:3964–3972. 1999.
7.
AskariAT, UnzekS, PopovicZB, GoldmanCK, ForudiFet al.Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet, 362:697–703. 2003.
8.
AssmusB, HonoldJ, SchachingerV, BrittenMB, Fischer-RasokatUet al.Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med, 355:1222–1232. 2006.
9.
AssmusB, SchachingerV, TeupeC, BrittenM, LehmannRet al.Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI)Circulation, 106:3009–3917. 2002.
10.
BeckerRC, AndreottiF. Preoteomics, metabolomics and progenitor cells in acute coronary syndromes. J Thromb Thrombol, 22:85–88. 2006.
11.
BrazmaA, HingampP, QuackenbushJ, SherlockG, SpellmanPet al.Minimum information about a microarray experiment (MIAME) toward standards for microarray data. Nat Genet, 29:365–371. 2001.
12.
BreitlingR, ArmengaudP, AmtmannA, HerzykP. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett, 573:83–92. 2004.
13.
BryderD, RossiDJ, WeissmanIL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol, 169:338–346. 2006.
14.
CapocciaBJ, RobsonDL, LevacKD, MaxwellDJ, HohmSAet al.Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood, 113:5340–5351. 2009.
15.
CarmelietP. Angiogenesis in life, disease and medicine. Nature, 438:932–936. 2005.
16.
CasamassimiA, BalestrieriML, FioritoC, SchianoC, MaioneCet al.Comparison between total endothelial progenitor cell isolation versus enriched Cd133+ culture. J Biochem, 141:503–511. 2007.
17.
CaseJ, MeadLE, BesslerWK, PraterD, WhiteHAet al.Human CD34+ AC133+ VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol, 35:1109–1118. 2007.
18.
ChavakisE, AicherA, HeeschenC, SasakiKi, KaiserRet al.Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med, 201:63–72. 2005.
19.
ChavakisE, KoyanagiM, DimmelerS. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation, 121:325–335. 2010.
20.
ChenH, CampbellRA, ChangY, LiM, WangCSet al.Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis. Blood, 113:1992–2002. 2009.
21.
ChenJZ, ZhangFR, TaoQM, WangXX, ZhuJH, ZhuJH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci, 107:273–280. 2004.
22.
ChenLA, LiJ, SilvaSR, JacksonLN, ZhouYet al.PKD3 is the predominant protein kinase D isoform in mouse exocrine pancreas and promotes hormone-induced amylase secretion. J Biol Chem, 284:2459–2471. 2009.
23.
DebA, PattersonC. Hard luck stories: the reality of endothelial progenitor cells continues to fall short of the promise. Circulation, 121:850–852. 2010.
24.
DennisG, ShermanB, HosackD, YangJ, GaoWet al.DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol, 4:3. 2003.
25.
DernbachE, UrbichC, BrandesRP, HofmannWK, ZeiherAM, DimmelerS. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood, 104:3591–3597. 2004.
26.
DesaiA, GlaserA, LiuD, RaghavachariN, BlumAet al.Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol, 29:121–127. 2009.
27.
Editors comment: To affinity … and beyond!Nat Genet, 14:367–370. 1996.
28.
ElsheikhE, UzunelM, HeZ, HolgerssonJ, NowakG, Sumitran-HolgerssonS. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood, 106:2347–2355. 2005.
29.
EsperRM, LoebJA. Neurotrophins induce neuregulin release through protein kinase Cdelta activation. J Biol Chem, 284:26251–26260. 2009.
30.
FadiniGP, AgostiniC, AvogaroA. Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature. Atherosclerosis, 209:10–17. 2010.
31.
FadiniGP, CoracinaA, BaessoI, AgostiniC, TiengoAet al.Peripheral blood CD34+ KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke, 37:2277–2282. 2006.
32.
FadiniGP, MiorinM, FaccoM, BonamicoS, BaessoIet al.Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol, 45:1449–1457. 2005.
33.
FadiniGP, SartoreS, AlbieroM, BaessoI, MurphyEet al.Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol, 26:2140–2146. 2006.
34.
Fernandez PujolB, LucibelloFC, GehlingUM, LindemannK, WeidnerNet al.Endothelial-like cells derived from human CD14 positive monocytes. Differentiation, 65:287–300. 2000.
35.
FioritoC, RienzoM, CrimiE, RossielloR, Luisa BalestrieriMet al.Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. Free Radic Res, 42:754–762. 2008.
36.
FloreyHW, GreerSJ, PooleJC, WerthessenNT. The pseudointima lining fabric grafts of the aorta. Br J Exp Pathol, 42:236–246. 1961.
FolkmanJ. What is the role of endothelial cells in angiogenesis?Lab Invest, 51:601–604. 1984.
39.
FuchsS, HermannsMI, KirkpatrickCJ. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res, 326:79–92. 2006.
40.
GarlandaC, DejanaE. Heterogeneity of endothelial cells: specific markers. Arterioscler Thromb Vasc Biol, 17:1193–1202. 1997.
41.
GolubTR, SlonimDK, TamayoP, HuardC, GaasenbeekMet al.Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286:531–537. 1999.
42.
GrunewaldM, AvrahamI, DorY, Bachar-LustigE, ItinAet al.VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell, 124:175–189. 2006.
43.
HagensenMK, ShimJ, ThimT, FalkE, BentzonJF. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation, 121:898–905. 2010.
44.
HankeyGJ, NormanPE, EikelboomJW. Medical treatment of peripheral arterial disease. JAMA, 295:547–553. 2006.
45.
HeeschenC, AicherA, LehmannR, FichtlschererS, VasaMet al.Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood, 102:1340–1346. 2003.
46.
HeeschenC, LehmannR, HonoldJ, AssmusB, AicherAet al.Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109:1615–1622. 2004.
47.
HeissigB, HattoriK, DiasS, FriedrichM, FerrisBet al.Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109:625–637. 2002.
HillJM, ZalosG, HalcoxJPJ, SchenkeWH, WaclawiwMAet al.Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 348:593–600. 2003.
50.
HirschA, NijveldtR, van der VleutenPA, BiemondBJ, DoevendansPAet al.Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial: a prospective, multicenter, randomized trial. Am Heart J, 152:434–441. 2006.
51.
HongF, BreitlingR, McEnteeCW, WittnerBS, NemhauserJL, ChoryJ. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics, 22:2825–2827. 2006.
52.
HuangP, LiS, HanM, XiaoZ, YangR, HanZC. Autologoust transplantation of granulocyte colony stimulating factor μobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care, 28:2155–2160. 2005.
53.
HuangPH, ChenYH, TsaiHY, ChenJS, WuTCet al.Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol, 30:869–877. 2010.
54.
HuangPH, ChenYH, WangCH, ChenJS, TsaiHYet al.Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol, 29:1179–1184. 2009.
55.
HumeDA, SummersKM, RazaS, BaillieJK, FreemanTC. Functional clustering and lineage markers: insights into cellular differentiation and gene function from large-scale microarray studies of purified primary cell populations. Genomics, 2010(in press).
56.
HurJ, YoonCH, KimHS, ChoiJH, KangHJet al.Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol, 24:288–293. 2004.
IngramDA, MeadLE, TanakaH, MeadeV, FenoglioAet al.Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 104:2752–2760. 2004.
JainAK, MurtyMN, FlynnPJ. Data clustering: a review. ACM Comput Surv, 31:264–323. 1999.
61.
JieKE, ZaikovaMA, BergevoetMWT, WesterweelPE, RastmaneshMet al.Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol Dial Transplant, 25:1875–1882. 2010.
62.
KalkaC, MasudaH, TakahashiT, Kalka-MollWM, SilverMet al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A, 97:3422–3427. 2000
63.
KennedyLJJr, WeissmanIL. Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N Engl J Med, 285:884–887. 1971.
KolbeM, DohleE, KaterlaD, KirkpatrickCJ, FuchsS. Enrichment of outgrowth endothelial cells in high and low colony-forming cultures from peripheral blood progenitors. Tissue Eng Part C Methods, 16:877–886. 2010.
66.
KrenningG, van der StrateBW, SchipperM, van SeijenXJ, FernandesBCet al.CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med, 13:2521–2533. 2009.
67.
KukiS, ImanishiT, KobayashiK, MatsuoY, ObanaM, AkasakaT. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J, 70:1076–1081. 2006.
68.
LancrinC, SroczynskaP, SerranoA, GandilletA, FerrerasCet al.Blood cell generation from the hemangioblast. J Mol Med, 88:167–172. 2010.
69.
LanderES, LintonLM, BirrenB, NusbaumC, ZodyMCet al.Initial sequencing and analysis of the human genome. Nature, 409:860–921. 2001.
70.
LiB, CohenA, HudsonTE, MotlaghD, AmraniDL, DuffieldJS. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation, 121:2211–2220. 2010.
71.
LibbyP. Inflammation in atherosclerosis. Nature, 420:868–874. 2002.
72.
LinY, WeisdorfDJ, SoloveyA, HebbelRP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest, 105:71–77. 2000.
73.
LockhartDJ, DongH, ByrneMC, FollettieMT, GalloMVet al.Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotech, 14:1675–1680. 1996.
74.
LockhartDJ, WinzelerEA. Genomics, gene expression and DNA arrays. Nature, 405:827–836. 2000.
75.
LoomansCJM, De KoningEJP, StaalFJT, RabelinkTJ, ZonneveldAJV. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?Antioxid Redox Signal, 7:1468–1475. 2005.
LukkM, KapusheskyM, NikkilaJ, ParkinsonH, GoncalvesAet al.A global map of human gene expression. Nat Biotech, 28:322–324. 2010.
78.
MacArthurBD, TareRS, MurawskiK, OreffoRO. Identification of candidate regulators of multipotency in human skeletal progenitor cells. Biochem Biophys Res Commun, 377:68–72. 2008.
79.
MackayJ, MensahG. The Atlas of Heart Disease and Stroke. Geneva: World Health Organization, 2004.
MedinaR, O'NeillC, SweeneyM, Guduric-FuchsJ, GardinerTet al.Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics, 3:18. 2010.
84.
MichowitzY, GoldsteinE, WexlerD, ShepsD, KerenG, GeorgeJ. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart, 93:1046–1050. 2007.
85.
MinamiY, SatohM, MaesawaC, TakahashiY, TabuchiTet al.Effect of atorvastatin on microRNA 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest, 39:359–367. 2009.
86.
MukaiN, AkahoriT, KomakiM, LiQ, Kanayasu-ToyodaTet al.A comparison of the tube-forming potentials of early and late endothelial progenitor cells. Exp Cell Res, 314:430–440. 2008.
87.
NorgrenL, HiattWR, DormandyJA, NehlerMR, HarrisKA, FowkesFGR. Inter-society consensus for the management of peripheral arterial disease (TASC II)J Vasc Surg, 45:S5–S67. 2007.
PeetersSDPW, van der KolkDM, de HaanG, BystrykhL, KuipersFet al.Selective expression of cholesterol metabolism genes in normal CD34+ CD38- cells with a heterogeneous expression pattern in AML cells. Exp Hematol, 34:622–630. 2006.
90.
PeichevM, NaiyerAJ, PereiraD, ZhuZ, LaneWJet al.Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood, 95:952–958. 2000.
91.
PeledA, KolletO, PonomaryovT, PetitI, FranitzaSet al.The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood, 95:3289–3296. 2000
92.
PiaggioG, RostiV, CorselliM, BertolottiF, BergamaschiGet al.Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood, 114:3127–3130. 2009.
93.
PooleJC, SabistonDCJr, FloreyHW, AllisonPR. Growth of endothelium in arterial prosthetic grafts and following endarterectomy. Surg Forum, 13:225–227. 1962.
94.
PraterDN, CaseJ, IngramDA, YoderMC. Working hypothesis to redefine endothelial progenitor cells. Leukemia, 21:1141–1149. 2007.
95.
ProkopiM, PulaG, MayrU, DevueC, GallagherJet al.Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood, 114:723–732. 2009.
96.
PulaG, MayrU, EvansC, ProkopiM, VaraDSet al.Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures. Circ Res, 104:32–40. 2009.
97.
RehmanJ, LiJ, OrschellCM, MarchKL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107:1164–1169. 2003.
98.
ReinischA, HofmannNA, ObenaufAC, KashoferK, RohdeEet al.Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood, 113:6716–6725. 2009.
99.
RhodesDR, YuJ, ShankerK, DeshpandeN, VaramballyRet al.Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A, 101:9309–9314. 2004.
100.
RisauW. Mechanisms of angiogenesis. Nature, 386:671–674. 1997.
101.
RisauW, FlammeI. Vasculogenesis. Annu Rev Cell Dev Biol, 11:73–91. 1995.
102.
RohdeE, BartmannC, SchallmoserK, ReinischA, LanzerGet al.Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells, 25:1746–1752. 2007.
103.
RomagnaniP, AnnunziatoF, LiottaF, LazzeriE, MazzinghiBet al.CD14+ CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res, 97:314–322. 2005.
104.
RookmaakerMB, VergeerM, van ZonneveldAJ, RabelinkTJ, VerhaarMCet al.Endothelial progenitor cells: mainly derived from the monocyte/macrophage-containing CD34- mononuclear cell population and only in part from the hematopoietic stem cell-containing CD34+ mononuclear cell population response. Circulation, 108:e150. 2003.
105.
RueggC, TissotJD, FarmerP, MariottiA. Omics meets hypothesis-driven research: partnership for innovative discoveries in vascular biology and angiogenesis. Thromb Haemost, 100:738–746. 2008.
106.
SaraH, KallioniemiO, NeesM. A decade of cancer gene profiling: from molecular portraits to molecular function. Methods Mol Biol, 576:61–87. 2010.
107.
SchirmerSH, FledderusJO, BotPTG, MoerlandPD, HoeferIEet al.Interferon-{beta} signaling Is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res, 102:1286–1294. 2008.
108.
SchmeisserA, GarlichsCD, ZhangH, EskafiS, GraffyCet al.Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res, 49:671–680. 2001.
109.
Schmidt-LuckeC, RossigL, FichtlschererS, VasaM, BrittenMet al.Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation, 111:2981–2987. 2005.
110.
SeegerFH, TonnT, KrzossokN, ZeiherAM, DimmelerS. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J, 28:766–772. 2007.
111.
SievekingDP, BuckleA, CelermajerDS, NgMKC. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol, 51:660–668. 2008.
112.
SorrentinoSA, BahlmannFH, BeslerC, MullerM, SchulzSet al.Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-{gamma} agonist rosiglitazone. Circulation, 116:163–173. 2007.
113.
SprengersRW, MollFL, TeraaM, VerhaarMC. Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia. J Vasc Surg, 51:1564–1568. 2010.
114.
StastnaM, AbrahamMR, Van EykJE. Cardiac stem/progenitor cells, secreted proteins, and proteomics. FEBS Lett, 583:1800–1807. 2009.
115.
StrauerBE, BrehmM, ZeusT, KosteringM, HernandezAet al.Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 106:1913–1918. 2002.
116.
StumpMM, JordanGLJr, DebakeyME, HalpertB. Endothelium grown from circulating blood on isolated intravascular dacron hub. Am J Pathol, 43:361–367. 1963.
117.
TakahashiT, KalkaC, MasudaH, ChenD, SilverMet al.Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med, 5:434–438. 1999.
118.
TanK, LessieurE, CutlerA, NeroneP, VasanjiAet al.Impaired function of circulating CD34+ CD45- cells in patients with proliferative diabetic retinopathy. Exp Eye Res, 2010(in press).
119.
Tateishi-YuyamaE, MatsubaraH, MuroharaT, IkedaU, ShintaniSet al.Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet, 360:427–435. 2002.
120.
TepperOM, GalianoRD, CaplaJM, KalkaC, GagnePJet al.Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 106:2781–276. 2002.
UrbichC, AicherA, HeeschenC, DernbachE, HofmannWKet al.Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol, 39:733–742. 2005.
123.
UrbichC, HeeschenC, AicherA, DernbachE, ZeiherAM, DimmelerS. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation, 108:2511–2516. 2003.
124.
UrbichC, HeeschenC, AicherA, SasakiKi, BruhlTet al.Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med, 11:206–213. 2005.
125.
van BeemRT, NoortWA, VoermansC, KleijerM, ten BrinkeAet al.The presence of activated CD4+ T cells is essential for the formation of colony-forming unit-endothelial cells by CD14+ cells. J Immunol, 180:5141–5148. 2008.
126.
van der PuttenK, JieKE, EmansME, VerhaarMC, JolesJAet al.Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study. J Nephrol, 2010(in press).
127.
van OostromO, de KleijnD, FledderusJ, PescatoriM, StubbsAet al.Folic acid supplementation normalizes the endothelial progenitor cell transcriptome of patients with type 1 diabetes: a case-control pilot study. Cardiovasc Diabetol, 8:47. 2009.
128.
van RoyenN, SchirmerSH, AtaseverB, BehrensCYH, UbbinkDet al.START Trial: a pilot study on sTimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation, 112:1040–1046. 2005.
129.
VasaM, FichtlschererS, AicherA, AdlerK, UrbichCet al.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 89:E1–E7. 2001.
130.
VasaM, FichtlschererS, AdlerK, AicherA, MartinHet al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 103:2885–2890. 2001.
131.
VenterJC, AdamsMD, MyersEW, LiPW, MuralRJet al.The sequence of the human genome. Science, 291:1304–1351. 2001.
132.
WalterDH, HaendelerJ, ReinholdJ, RochwalskyU, SeegerFet al.Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res, 97:1142–1151. 2005.
133.
WatkinsNA, GusnantoA, de BonoB, DeS, Miranda-SaavedraDet al.A haematlas: characterizing gene expression in differentiated human blood cells. Blood, 113:e1–e9. 2009.
134.
WeigeltB, Reis-FilhoJS. Histological and molecular types of breast cancer: is there a unifying taxonomy?Nat Rev Clin Oncol, 6:718–730. 2009.
135.
WernerC, KamaniCH, GenschC, BahmM, LaufsU. The peroxisome proliferator activated receptor-agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes, 56:2609–2615. 2007.
136.
WernerN, KosiolS, SchieglT, AhlersP, WalentaKet al.Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 353:999–1007. 2005.
137.
WestenbrinkBD, LipicE, van der MeerP, van der HarstP, OeseburgHet al.Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J, 28:2018–2027. 2007.
138.
WesterweelPE, denOK, NguyenTQ, GoldschmedingR, JolesJA, VerhaarMC. Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing. Am J Physiol Renal Physiol, 294:F379–F384. 2008.
139.
WesterweelPE, VisserenFL, HajerGR, OlijhoekJK, HoeferIEet al.Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur Heart J, 29:2808–2817. 2008.
140.
WinnepenninckxV, LazarV, MichielsS, DessenP, StasMet al.Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst, 98:472–482. 2006.
141.
Writing Group. RosamondW, FlegalK, FurieK, GoAet al.Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 117:e25–e146. 2008.
YoderMC, MeadLE, PraterD, KrierTR, MrouehKNet al.Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109:1801–1809. 2007.
144.
YoonCH, HurJ, ParkKW, KimJH, LeeCSet al.Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation, 112:1618–1627. 2005.
145.
ZeisbergerSM, ZollerS, RiegelM, ChenS, KrenningGet al.Optimization of the culturing conditions of human umbilical cord blood-derived endothelial colony-forming cells under xeno-free conditions applying a transcriptomic approach. Genes Cells, 15:671–687. 2010.
146.
ZemaniF, SilvestreJS, Fauvel-LafeveF, BruelA, VilarJet al.Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol, 28:644–650. 2008.
147.
ZhangSJ, ZhangH, WeiYJ, SuWJ, LiaoZKet al.Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res, 16:577–584. 2006.
148.
ZhaoT, LiJ, ChenAF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab, 299:E110–E116. 2010.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
